Bexarotene Capsule
Product Images NDC 0832-0285

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0832-0285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bexarotene 01)

Chemical structure diagram of bexarotene, showing its molecular framework with carbon atoms and functional groups including a carboxylic acid (COOH) moiety.*

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

Bexarotene Capsules 75 mg oral capsules label showing a package of 100 capsules. It includes warnings about storage between 2° to 25°C and advises avoiding exposure to heat, humidity, and light. The label states the product is manufactured for Upsher-Smith Laboratories, LLC, with a note of being made in New Zealand. Active and inactive ingredients are listed, along with a barcode and prescription-only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.